Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Matteo Piovella, SOE 2019 – Presbyopia correction; adopting multifocal IOLs

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 17th 2019

Matteo Piovella, Director of the Center for Outpatient Microsurgery, Monza, Italy discusses the latest updates in presbyopia correction adopting multifocal IOLs at SOE 2019.

Part 1:
1. What are the major causes of patient dissatisfaction with presbyopia-correcting multifocal IOLs? (0:04)
2. What are the advantages of small aperture pinhole IOLs to correct presbyopia and astigmatism? (2:34)
3. Could you tell us a little about the study you are presenting on the AcuFocus IC-8 IOL? (5:58)

Part 2:
1. Which patients will benefit most from these lenses? (0:05)

Filmed in partnership with European Society of Ophthalmology (SOE).

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup